Enact Holdings, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Enact Holdings, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.24B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.20B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $1.15B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $1.10B | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $1.12B | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $1.11B | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $978.85M | Feb 28, 2022 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $674.24M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $688.07M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $665.51M | Feb 27, 2026 |
| FY2021 | Dec 31, 2021 | $546.69M | Feb 28, 2022 |
| FY2021 | Dec 31, 2020 | $370.42M | Feb 28, 2022 |
| FY2021 | Dec 31, 2019 | $677.63M | Feb 28, 2022 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $208.33M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $213.31M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $212.49M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $226.94M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $231.45M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $215.02M | Feb 28, 2023 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $724.52M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $686.26M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $632.04M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $560.51M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $572.11M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $704.35M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $500.02M | Feb 28, 2022 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.89B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $6.52B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $6.19B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $5.71B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $5.87B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $5.65B | Feb 28, 2022 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.54B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.53B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $1.56B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $1.61B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $1.76B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $1.77B | Feb 28, 2022 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.36B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $5.00B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $4.63B | Feb 27, 2026 |
| FY2025 | Dec 31, 2022 | $4.10B | Feb 27, 2026 |
| FY2024 | Dec 31, 2021 | $4.11B | Feb 28, 2025 |
| FY2023 | Dec 31, 2020 | $3.88B | Feb 29, 2024 |
| FY2022 | Dec 31, 2019 | $3.83B | Feb 28, 2023 |
| FY2021 | Dec 31, 2018 | $3.27B | Feb 28, 2022 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.68B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $3.13B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $2.55B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $2.10B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $1.65B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $1.30B | Feb 28, 2022 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $582.49M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $599.43M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $615.68M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $513.78M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $425.83M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $452.79M | Feb 28, 2022 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $744.48M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $743.05M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $745.42M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $742.83M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $740.42M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $738.16M | Feb 28, 2022 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 4 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 4 | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 4 | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | 3 | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | 2 | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | 4 | Feb 28, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 4 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 4 | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 4 | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | 3 | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | 2 | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | 4 | Feb 28, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 142.21M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 152.32M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | 159.34M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | 162.78M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | 162.84M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | 162.84M | Feb 28, 2022 |